Tech Company Financing Transactions
Danube Pharmaceuticals Funding Round
Danube Pharmaceuticals, operating out of New York, secured $10 million in funding from private investors.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$10,001,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
689 5th Avenue 14th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Danube Pharmaceuticals is an entrepreneurial, science-driven biopharmaceutical company involved in early-stage clinical research. We are dedicated to serving the medical community with integrity while assisting patients fight serious illness through the development of novel therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Guyer
Chief Executive Officer
Barrett Katz
Chief Operating Officer
Brian Levy
VP - Operations
Yordak Salermo
Browse more venture capital transactions:
Prev: 6/30/2006: Simpler Networks venture capital transaction
Next: 6/30/2006: TagWorld venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs